Voya Investment Management LLC increased its holdings in Patheon NV (NASDAQ:PTHN) by 10.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,030 shares of the company’s stock after buying an additional 1,235 shares during the period. Voya Investment Management LLC’s holdings in Patheon NV were worth $454,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of PTHN. Russell Investments Group Ltd. bought a new position in Patheon NV in the second quarter worth approximately $119,000. Seven Eight Capital LP bought a new position in Patheon NV in the second quarter worth approximately $136,000. Pacad Investment Ltd. bought a new position in Patheon NV in the second quarter worth approximately $164,000. Utah Retirement Systems bought a new position in Patheon NV in the second quarter worth approximately $212,000. Finally, Amalgamated Bank bought a new position in Patheon NV in the second quarter worth approximately $222,000.

Patheon NV has a 12-month low of $23.72 and a 12-month high of $35.13.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/11/08/voya-investment-management-llc-acquires-1235-shares-of-patheon-nv-pthn.html.

A number of equities analysts recently commented on the stock. BidaskClub downgraded shares of Patheon NV from a “sell” rating to a “strong sell” rating in a research note on Saturday, September 2nd. Jefferies Group LLC reissued a “hold” rating and issued a $35.00 price objective on shares of Patheon NV in a research note on Friday, July 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company’s stock. Patheon NV presently has an average rating of “Hold” and a consensus price target of $33.60.

Patheon NV Company Profile

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.

Want to see what other hedge funds are holding PTHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Patheon NV (NASDAQ:PTHN).

Institutional Ownership by Quarter for Patheon NV (NASDAQ:PTHN)

Receive News & Ratings for Patheon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon NV and related companies with MarketBeat.com's FREE daily email newsletter.